Improvement in Individual Symptoms and Total Symptom Score (TSS) and Matching-Adjusted Indirect Comparison (MAIC) Analysis to Compare TSS As a Continuous Endpoint in Patients with Myelofibrosis Treated with Pelabresib in Combination with Ruxolitinib Versus Janus Kinase Inhibitor Monotherapy

Bibliographische Detailangaben

Veröffentlicht in:	Blood 2022-11, Vol.140 (Supplement 1), p.11056-11059
Hauptverfasser:	Mesa, Ruben, Kremyanskaya, Marina, Patriarca, Andrea, Gupta, Vikas, Palandri, Francesca, Devos, Timothy, Harrison, Claire, Rampal, Raajit K., Talpaz, Moshe, Vannucchi, Alessandro, Kuykendall, Andrew, Kiladjian, Jean-Jacques, Verstovsek, Srdan, Colak, Gozde, Dey, Debarshi, Mascarenhas, John
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!